CPC Biotech
CPC Biotech supplies sterile connectors, low-shear pumps, flow meters, and sensors to biopharmaceutical manufacturers and cell therapy producers globally. Operating within Dover Corporation's Pump Solutions Group, the company serves biologic drug and cell therapy manufacturing customers across more than 50 countries.
- Company typePrivate
- Founded2006
- HeadquartersMonza, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CPC Biotech does
CPC Biotech is a biopharmaceutical fluid management component supplier operating as a wholly-owned unit within Dover Corporation's Pump Solutions Group (PSG). The company was formally launched in April 2026 by merging the connector technology of CPC with the flow control expertise of PSG Biotech, repositioning the combined franchise as a single-source provider of sterile connectors, low-shear pumps, flow meters, and sensors for upstream and downstream biologic drug manufacturing as well as cell and gene therapy production.
The product portfolio centers on aseptic connection technology and flow control hardware. Flagship lines include the AseptiQuik G PPSU HT Series connectors made of BPA-free polyphenylsulfone, designed to withstand autoclave sterilization at 130°C and chemical exposure across pH 2-12 including sodium hydroxide, benzyl alcohol, and DMSO, and the MicroCNX Nano Series connectors engineered for robotic gripper manipulation to support sterile, human-free cell therapy production. The portfolio leverages Dover's manufacturing footprint across North America, Europe, and Asia to serve biopharmaceutical and cell therapy manufacturers in more than 50 countries.
CPC Biotech operates as a B2B industrial manufacturer, generating revenue through hardware sales of components to biopharmaceutical manufacturers via direct enterprise field sales and industrial distribution channels. The company made its public debut at INTERPHEX 2026 in New York City and announced a strategic co-development partnership with Multiply Labs in May 2026 to integrate MicroCNX connectors with robotic cell therapy automation systems.
CPC Biotech firmographics
Firmographics- Name
- CPC Biotech
- Website
- https://cpcbiotech.it
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CPC Biotech supplies sterile connectors, low-shear pumps, flow meters, and sensors to biopharmaceutical manufacturers and cell therapy producers globally. Operating within Dover Corporation's Pump Solutions Group, the company serves biologic drug and cell therapy manufacturing customers across more than 50 countries.
- Ownership category
- akta.pro rank
CPC Biotech industry classification
Industry- Product category
- Biopharmaceutical Processing Equipment
- NAICS
- Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914), Plastics Pipe and Pipe Fitting Manufacturing (326122)
- SIC
- Pumps & Pumping Equipment (3561), Gaskets, Packg & Sealg Devices & Rubber & Plastics Hose (3050)
- akta.pro primary industry
- Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC)
- akta.pro secondary industry
- Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)
Keywords
Where CPC Biotech is headquartered
LocationHeadquarters
- HQ city
- Monza
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
CPC Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Biopharmaceutical Component Sales: CPC Biotech generates revenue through the sale of sterile connectors, low-shear pumps, flow meters, and sensors for the biopharmaceutical processing industry. The company serves as a combined entity merging CPC's connector technology with PSG Biotech's flow control expertise.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
CPC Biotech product offering
Product offeringCore offering
CPC Biotech manufactures and sells fluid management components for the biopharmaceutical industry, including sterile and aseptic connectors, low-shear pumps, flow meters, and sensors used in upstream and downstream biologic drug manufacturing and in cell and gene therapy production. The portfolio integrates CPC's connector technology with PSG Biotech's flow control expertise into a single-source offering for bioprocessing customers globally.
Product overview
CPC Biotech operates as a comprehensive biopharmaceutical fluid management company, combining the connector technology of CPC with the flow control expertise of PSG Biotech under Dover Corporation's Pump Solutions Group. The portfolio includes the MicroCNX® Nano Series robot-optimized aseptic connectors (for automated cell therapy manufacturing), the AsepticQuik G PPSU HT Series high-temperature connectors, low-shear pumps, flow meters, and sensors. The company serves customers in more than 50 countries across North America, Europe, and Asia, focusing on upstream and downstream biologic drug manufacturing as well as cell and gene therapy production. The recent partnership with Multiply Labs extends the product line into robotic automation for cell therapy manufacturing, while the AsepticQuik G PPSU HT Series addresses high-temperature and chemically harsh bioprocess applications.
Differentiator
Problem solved
Functional benefit
Brands
- MicroCNX Nano Series: Robot-optimized aseptic connectors for cell therapy manufacturing
- AseptiQuik G PPSU HT Series
Products and services
- MicroCNX Nano Series Aseptic Connectors Robot-optimized aseptic connectors designed for manipulation by robotic grippers, enabling sterile cell therapy production without human operators in automated cell therapy manufacturing workflows.
- AseptiQuik G PPSU HT Series Connectors High-temperature sterile connectors made of polyphenylsulfone (PPSU) for chemically harsh bioprocess applications, with BPA-free composition, pH 2-12 chemical resistance, and autoclave compatibility up to 130°C. Backward-compatible with existing AseptiQuik G products.
- Low-Shear Pumps Flow control pumps designed for sensitive biopharmaceutical fluid handling, providing low-shear transfer of biologic fluids in upstream and downstream bioprocessing.
- Flow Meters and Sensors Flow measurement and sensing components for biopharmaceutical processing, combined with connector technology to deliver an integrated fluid management solution for biologic drug manufacturing and cell and gene therapy production.
Quantifiable outcome
- Improved scalability and affordability of cell therapies through robotic automation
- +2 more outcomes
Companies that use CPC Biotech
Customer profileSegments2 records
Ideal customer profiles2 records
CPC Biotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CPC Biotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Multiply LabscoreCPC Biotech partnered with Multiply Labs to develop robotic systems for cell therapy manufacturing automation. The collaboration centers on CPC Biotech's robot-optimized MicroCNX Nano Series aseptic connector designed for manipulation by robotic grippers, combined with Multiply Labs' robotic interface. Both companies aim to address manufacturing bottlenecks and contamination risks in cell therapy production while maximizing production capacity in compact footprints to enable scale and affordability.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
CPC Biotech competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CPC Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
CPC Biotech leadership team
Management profileNumber of profiles
Profiles1 record
CPC Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CPC Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CPC Biotech
What does CPC Biotech do?
CPC Biotech manufactures and sells fluid management components for the biopharmaceutical industry, including sterile and aseptic connectors, low-shear pumps, flow meters, and sensors used in upstream and downstream biologic drug manufacturing and in cell and gene therapy production. The portfolio integrates CPC's connector technology with PSG Biotech's flow control expertise into a single-source offering for bioprocessing customers globally.
Is CPC Biotech a public or private company?
CPC Biotech is a private company. It is classified as corporate owned and is currently operating.
When was CPC Biotech founded?
CPC Biotech was founded in 2006. It employs 11 to 50 people.
Where is CPC Biotech based?
CPC Biotech is headquartered in Monza, Italy, in the Europe region.
How does CPC Biotech make money?
One revenue line is on record: biopharmaceutical Component Sales.
Does CPC Biotech have an API?
No public API is recorded for CPC Biotech.
What industry is CPC Biotech in?
CPC Biotech's product category is Biopharmaceutical Processing Equipment. Its primary akta.pro industry code is HLAAAJAC, Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors), with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 333914 and its SIC code is 3561.